Skip to content

Amiloride / Furosemide

    Amiloride / Furosemide

    DAE Class; Rx

    Common Brand Names; FRUMIL

    • Loop Diuretics Potassium-Sparing Diuretics And Aldosterone Antagonists Potassium-Sparing Diuretics With Other Diuretics

    Ascites and oedema associated with hepatic cirrhosis
    Congestive cardiac failure
    Diuresis (potassium sparing) in nephrosis
    Diuresis (potassium sparing) required due to corticosteroid therapy
    Diuresis (potassium sparing) required due to oestrogen therapy
    Prompt diuresis especially where potassium conservation is important

    Acute renal failure
    Addison’s disease
    Anuria
    Breastfeeding
    Electrolyte imbalance
    Galactosaemia
    Hyperkalaemia
    Hypovolaemia
    Long QT syndrome
    Pre-coma associated with hepatic cirrhosis
    Pregnancy
    Renal damage secondary to nephrotoxic agents
    Renal impairment – creatinine clearance below 30ml/minute/1.73m sq
    Renal impairment associated with hepatic coma
    Renal impairment secondary to hepatotoxic agents
    Severe hypokalaemia
    Severe hyponatraemia
    Torsade de pointes

    Side Effects

    Abdominal pain
    Acute generalised exanthematous pustulosis
    Agranulocytosis
    Allergic reaction
    Alopecia
    Altered liver function tests
    Anaphylactoid reaction
    Anaphylaxis
    Angina
    Anorexia
    Aplastic anaemia
    Arthralgia
    Bone marrow depression
    Bullous pemphigoid
    Cardiac arrhythmias
    Cholestatic jaundice
    Confusion
    Constipation
    Deafness
    Decreased glucose tolerance
    Dehydration
    Delayed reactions
    Diarrhoea
    Dizziness
    Drowsiness
    Drug rash with eosinophilia and systemic symptoms (DRESS)
    Dry mouth
    Eosinophilia
    Erythema multiforme
    Exacerbation of systemic lupus erythematosus
    Exfoliative dermatitis
    Fever
    Fluid and electrolyte disturbances
    Gastric upset
    Gastro-intestinal symptoms
    Glycosuria
    Gout
    Haemolytic anaemia
    Headache
    Hepatic encephalopathy
    Hyperglycaemia
    Hyperkalaemia
    Hypersensitivity reactions
    Hyperuricaemia
    Hypocalcaemia
    Hypokalaemia
    Hypomagnesaemia
    Hyponatraemia
    Hypotension
    Hypovolaemia
    Impaired concentration
    Increase in blood urea nitrogen
    Increase in plasma cholesterol
    Increase in plasma triglyceride concentration
    Increased calcium excretion
    Increased intra-ocular pressure
    Interstitial nephritis
    Leucopenia
    Light-headedness
    Malaise
    Metabolic acidosis
    Metabolic alkalosis
    Minor psychiatric disturbances
    Muscle cramps
    Nausea
    Nephrocalcinosis
    Nephrolithiasis
    Orthostatic hypotension
    Ototoxicity
    Pancreatitis
    Paraesthesia
    Photosensitivity
    Precipitation of diabetes
    Pruritus
    Purpura
    Rash
    Sensation of pressure
    Serum creatinine increased
    Sexual dysfunction
    Shock
    Skin reactions
    Stevens-Johnson syndrome
    Systemic lupus erythematosus
    Tetany
    Thirst
    Thrombocytopenia
    Tinnitus
    Toxic epidermal necrolysis
    Urinary retention
    Urticaria
    Vasculitis
    Visual disturbances
    Vomiting
    Weakness

    Children under 18 years
    Elderly
    Family history of long QT syndrome
    Hypoproteinaemia
    Predisposition to hypotension
    Predisposition towards electrolyte imbalance
    Benign prostatic hyperplasia
    Diabetes mellitus
    Glucose-galactose malabsorption syndrome
    Gout
    Hepato-renal syndrome
    History of torsade de pointes
    Hypotension
    Lactose intolerance
    Systemic lupus erythematosus
    Urinary obstruction

    Adjustment of hypoglycaemic therapy may be necessary in diabetes mellitus
    Correct electrolyte disorders before treatment
    Correct hypotension before initiating treatment
    May exacerbate or activate systemic lupus erythematosus
    Advise ability to drive/operate machinery may be affected by side effects
    Correct hypovolaemia prior to administration
    Contains lactose
    Consider monitoring ECG in patients at risk of QT prolongation
    Monitor blood urea
    Monitor fluid and electrolyte status
    Monitor haematological parameters regularly throughout treatment
    Monitor serum potassium regularly
    Excess consumption of liquorice may increase the risk of hypokalaemia
    Increased risk of hyperkalaemia with K+ suppl. and K+ sparing diuretic
    May precipitate diabetes mellitus
    May precipitate gout
    Discontinue treatment before glucose tolerance test
    Discontinue if evidence of significant bone marrow depression
    Withdraw drug if skin rash or pruritus occur
    Advise patient not to take NSAIDs unless advised by clinician
    Hypotensive effects may be potentiated by alcohol
    Advise on problems of salt substitutes/high intake of potassium-rich food

    Co-amilofruse is contraindicated in pregnancy.

    Adults

    Starting dose: 5mg amiloride + 40mg furosemide.
    Maintenance doses (all tablet strengths): 1 to 2 tablets in the morning.

    Amiloride / Furosemide

    Tablets

    • co-amilofruse (amiloride 10mg and furosemide 80mg) tablets
    • co-amilofruse (amiloride 2.5mg and furosemide 20mg) tablets
    • co-amilofruse (amiloride 5mg and furosemide 40mg) tablet